Cargando…

STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers

Although radiotherapy resistance is associated with locoregional recurrence and distant metastasis in breast cancers, clinically relevant molecular markers and critical signaling pathways of radioresistant breast cancer are yet to be defined. Herein, we show that HER2-STAT3-survivin regulation is as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae-Sung, Kim, Hyun-Ah, Seong, Min-Ki, Seol, Hyesil, Oh, Jeong Su, Kim, Eun-Kyu, Chang, Jong Wook, Hwang, Sang-Gu, Noh, Woo Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872768/ https://www.ncbi.nlm.nih.gov/pubmed/26755645 http://dx.doi.org/10.18632/oncotarget.6855

Ejemplares similares

Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
por: Ha, June-Hyung, et al.
Publicado: (2014)

Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature
por: Seong, Min‐Ki, et al.
Publicado: (2015)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
por: Choi, Jihye, et al.
Publicado: (2019)

The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer
por: Kim, Ji Yea, et al.
Publicado: (2022)

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer
por: Park, Chan Sub, et al.
Publicado: (2019)

Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
por: Choi, Jihye, et al.
Publicado: (2020)

Synergistic Effect of Sulindac and Simvastatin on Apoptosis in Lung Cancer A549 Cells through AKT-Dependent Downregulation of Survivin
por: Kim, Young-Suk, et al.
Publicado: (2015)

Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
por: Il Yu, Jeong, et al.
Publicado: (2016)

Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors
por: Jang, Yoon Jung, et al.
Publicado: (2021)

Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin
por: Lee, Tak Gyeom, et al.
Publicado: (2023)

Up-regulation of 5-lipoxygenase by inhibition of cathepsin G enhances TRAIL-induced apoptosis through down-regulation of survivin
por: Woo, Seon Min, et al.
Publicado: (2017)

Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer
por: Kim, Hyun-Ah, et al.
Publicado: (2013)

Down-Regulation of Survivin by Nemadipine-A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis
por: Park, Seong Ho, et al.
Publicado: (2013)

Giant juvenile fibroadenoma of the breast: a case report and brief literature review
por: Song, Bong Sup, et al.
Publicado: (2014)

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
por: Lee, Ho-chang, et al.
Publicado: (2013)

Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma
por: Woo, Seon Min, et al.
Publicado: (2019)

Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor
por: Woo, Sang Hyeok, et al.
Publicado: (2016)

Survivin expression and its clinical significance in pancreatic cancer
por: Lee, Myung Ah, et al.
Publicado: (2005)

Rhabdoid Colorectal Carcinomas: Reports of Two Cases
por: Lee, Sang Hwa, et al.
Publicado: (2013)

The Prediction of HER2-Targeted Treatment Response Using (64)Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report
por: Lee, Inki, et al.
Publicado: (2022)

Survivin is a novel transcription regulator of KIT and is downregulated by miRNA‐494 in gastrointestinal stromal tumors
por: Yun, SeongJu, et al.
Publicado: (2018)

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
por: Lee, Juhyeon, et al.
Publicado: (2023)

Survivin and Her2 Expressions in Different Grades of Urothelial Neoplasms of Urinary Bladder
por: Moradi Tabriz, Hedieh, et al.
Publicado: (2021)

Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5
por: Woo, Seon Min, et al.
Publicado: (2022)

Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression
por: KIM, SOO-AH, et al.
Publicado: (2014)

Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer
por: Kim, Hyun-Ah, et al.
Publicado: (2015)

Cases report of unicentric Castleman's disease: revisit of radiotherapy role
por: Noh, O Kyu, et al.
Publicado: (2013)

Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells
por: Nam, KeeSoo, et al.
Publicado: (2017)

Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death
por: Park, So Jung, et al.
Publicado: (2016)

PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
por: Kim, Ju Won, et al.
Publicado: (2023)

Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
por: Phi, Ji Hoon, et al.
Publicado: (2015)

STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin
por: Wang, Qiaoyu, et al.
Publicado: (2021)

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
por: Kim, Young A, et al.
Publicado: (2012)

Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
por: Kim, Tae Min, et al.
Publicado: (2018)

Radiotherapy for brain metastasis and long-term survival
por: Park, Kawngwoo, et al.
Publicado: (2021)

Interim Tumor Progression and Volumetric Changes of Surgical Cavities during the Surgery-to-Radiotherapy Interval in Anaplastic Gliomas: Implications for Additional Pre-radiotherapy Magnetic Resonance Imaging
por: Wee, Chan Woo, et al.
Publicado: (2020)

Inverse expression of survivin and reprimo correlates with poor patient prognosis in gastric cancer
por: Cerda-Opazo, Paulina, et al.
Publicado: (2018)

Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen
por: Chae, Han Kyu, et al.
Publicado: (2022)

Fulminant Meningitis after Radiotherapy for Clival Chordoma
por: Kim, Seong Min, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kop8reces2upf1bsc3qbo96t2d